Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 57 (2-3) , 249-266
- https://doi.org/10.1016/0021-9150(85)90038-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Treatment of type III hyperlipoproteinemia with four different treatment regimensAtherosclerosis, 1984
- Increased frequency of lipoprotein disorders similar to type iii hyperlipoproteinemia in survivors of myocardial infarction in JapanAtherosclerosis, 1984
- A new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosisAtherosclerosis, 1984
- HYPERLIPOPROTEINAEMIA TYPE V AND APOLIPOPROTEIN E4The Lancet, 1982
- Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.Journal of Clinical Investigation, 1982
- PHENOTYPE STUDY OF APOLIPOPROTEIN E ISOFORMS IN HYPERLIPOPROTEINAEMIC PATIENTSThe Lancet, 1982
- Long-term treatment of type III hyperlipoproteinemia with clofibrateAtherosclerosis, 1981
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- Ultracentrifugal evidence of a special subtype of mixed hyperlipidemiaAtherosclerosis, 1977
- Serum Lipoprotein Abnormalities in Patients with Ischaemic Heart Disease: Comparisons with a Control PopulationBMJ, 1974